Clinical Trial Update: A Study of Nivolumab and Chemotherapy Followed by Surgery for Mesothelioma [Phase 1]

View source ↗

Summary

Clinical trial update for Phase 1 study of Nivolumab plus chemotherapy followed by surgery in malignant pleural mesothelioma; the trial is currently active but …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Pleural Mesothelioma

Drugs mentioned

• nivolumab (nivolumab)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Malignant Pleural Mesothelioma | Phase 1 | Status: ACTIVE_NOT_RECRUITING